Prevalence of HBV and HCV among outpatients in the plovdiv region of Bulgaria, 2010–2011
- 27 August 2014
- journal article
- research article
- Published by Wiley in Journal of Medical Virology
- Vol. 87 (3) , 401-406
Abstract
Viral hepatitis, particularly hepatitis B and C, are diseases with worldwide distribution that present a significant public health problem. Seroprevalence studies allow assessment of the extent of the disease burden, the identification of populations at risk and the monitoring trends over time. A multi-center seroprevalence study, carried out in Bulgaria (covering the five largest cities – Sofia, Plovdiv, Varna, Pleven, and Stara Zagora) in 1999–2000 estimated a crude seroprevalence rate of 3.9% for HBsAg and 1.3% for anti-HCV. A decade later, comparable rates were observed in a study including 865 outpatients consulting a clinical laboratory in Plovdiv, the second largest administrative region in Bulgaria. The crude seroprevalence rate measured for hepatitis B (HBsAg) was 3.9%. The HBsAg prevalence rate in individuals ≤19 years of age (targeted by vaccination) was significantly lower compared to the rate in adults ≥20 years of age –1% versus 4.8%. The lack of dynamics in the overall level of HBsAg carriers is likely related to the excessively low hepatitis B vaccine coverage in individuals, born before the introduction of the universal vaccination of newborns in August 1991. Anti-HCV antibodies were detected in 0.7% of the subjects. J. Med. Virol. 87:401–406, 2015.Keywords
This publication has 11 references indexed in Scilit:
- Burden and prevention of viral hepatitis in BulgariaVaccine, 2011
- Seroprevalence and Risk Factors for Hepatitis B Infection in an Adult Population in Northeast ChinaInternational Journal of Medical Sciences, 2011
- Hepatitis B vaccines: WHO position paper—RecommendationsVaccine, 2010
- The natural history of chronic hepatitis B virus infection #Hepatology, 2009
- The changing pattern of hepatitis B virus infection over the past three decades in ItalyDigestive and Liver Disease, 2005
- Long-term clinical and histological outcomes in patients with spontaneous hepatitis B surface antigen seroclearanceJournal of Hepatology, 2005
- EU project interreg II: seroepidemiology study on hepatitis C and B viral infections prevalence in Bulgaria and nothern GreeceJournal of Hepatology, 2002
- Changes in the seroepidemiology of hepatitis B infection in Catalonia 1989–1996Vaccine, 2000
- HORIZONTAL TRANSMISSION OF HEPATITIS B VIRUSThe Lancet, 1989
- Postnatal Infectivity of Hepatitis B Surface Antigen-Carrier MothersThe Journal of Infectious Diseases, 1983